General

Showing 1601–1616 of 2270 results

Article: P2.08 Effect of different peak integration methods on the accuracy of paraprotein quantification on serum protein electrophoresis: what is the clinical relevance?
€3.03 Add to cart
Article: P2.08 Short delay of occurrence of myelodysplasia after Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NETs)
€3.03 Add to cart
Article: P2.09 Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia
€3.03 Add to cart
Article: P2.09 Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report
€3.03 Add to cart
Article: P2.09 Refractory anemia with ringed sideroblasts upon linezolid treatment
€3.03 Add to cart
Article: P2.10 Acquired von Willebrand disease in CML : a case report
€3.03 Add to cart
Article: P2.10 BRAF V600E mutation is not a disease-defining genetic event in classic hairy cell leukemia
€3.03 Add to cart
Article: P2.10 Role of Extracellular Vesicles for Thrombosis in Paroxysmal Nocturnal Hemoglobinuria patients
€3.03 Add to cart
Article: P2.11 Activating JAK1 and JAK3 mutations cooperate to confer growth signal self-sufficiency and increased resistance to JAK inhibitors in a mouse in vitro leukemia model
€3.03 Add to cart
Article: P2.12 An unusual presentation of cryptococcal meningitis in a patient with lymphoplasmacytic dyscrasia
€3.03 Add to cart
Article: P2.13 Management of refractory/relapsed diffuse large B-cell lymphoma (DLBCL): the gap between guidelines and real world
€3.03 Add to cart
Article: P2.14 Cost-utility of granulocyte-colony stimulating factors (G-CSFS) for primary prophylaxis (PP) of chemotherapy induced febrile neutropenia (FN) in non-Hodgkin’s lymphoma patients (NHL) in Belgium
€3.03 Add to cart
Article: P2.15 Flow cytometry characterization of micro-particles from healthy and malignant blood cells
€3.03 Add to cart
Article: P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model
€3.03 Add to cart
Article: P2.17 The respective value of the G8 screening and the Comprehensive Geriatric Assessment (CGA) for the identification of vulnerable older patients with hematological malignancies susceptible to benefit from chemotherapy
€3.03 Add to cart
Article: P2.18 Responding patients show durable responses to bendamustine in double refractory multiple myeloma patients
€3.03 Add to cart

Article: P2.08 Effect of different peak integration methods on the accuracy of paraprotein quantification on serum protein electrophoresis: what is the clinical relevance?

Article: P2.08 Short delay of occurrence of myelodysplasia after Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NETs)

Article: P2.09 Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia

Article: P2.09 Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report

Article: P2.09 Refractory anemia with ringed sideroblasts upon linezolid treatment

Article: P2.10 Acquired von Willebrand disease in CML : a case report

Article: P2.10 BRAF V600E mutation is not a disease-defining genetic event in classic hairy cell leukemia

Article: P2.10 Role of Extracellular Vesicles for Thrombosis in Paroxysmal Nocturnal Hemoglobinuria patients

Article: P2.11 Activating JAK1 and JAK3 mutations cooperate to confer growth signal self-sufficiency and increased resistance to JAK inhibitors in a mouse in vitro leukemia model

Article: P2.12 An unusual presentation of cryptococcal meningitis in a patient with lymphoplasmacytic dyscrasia

Article: P2.13 Management of refractory/relapsed diffuse large B-cell lymphoma (DLBCL): the gap between guidelines and real world

Article: P2.14 Cost-utility of granulocyte-colony stimulating factors (G-CSFS) for primary prophylaxis (PP) of chemotherapy induced febrile neutropenia (FN) in non-Hodgkin’s lymphoma patients (NHL) in Belgium

Article: P2.15 Flow cytometry characterization of micro-particles from healthy and malignant blood cells

Article: P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model

Article: P2.17 The respective value of the G8 screening and the Comprehensive Geriatric Assessment (CGA) for the identification of vulnerable older patients with hematological malignancies susceptible to benefit from chemotherapy

Article: P2.18 Responding patients show durable responses to bendamustine in double refractory multiple myeloma patients